Bank of Montreal’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-341
Closed -$238K 3720
2025
Q2
$238K Sell
341
-593
-63% -$1.44K ﹤0.01% 2707
2025
Q1
$252K Hold
934
﹤0.01% 2601
2024
Q4
$594K Sell
934
-1
-0.1% -$4 ﹤0.01% 2129
2024
Q3
$635K Hold
935
﹤0.01% 2267
2024
Q2
$601K Hold
935
﹤0.01% 2298
2024
Q1
$600K Hold
935
﹤0.01% 2325
2023
Q4
$606K Buy
+935
New +$3.64K ﹤0.01% 2368
2023
Q2
Sell
-3,974
Closed -$2.49M 4193
2023
Q1
$2.49M Buy
+3,974
New +$19.6K ﹤0.01% 1590
2022
Q2
Sell
-32,025
Closed -$23.3M 4311
2022
Q1
$23.3M Buy
32,025
+31,501
+6,012% +$215K 0.01% 754
2021
Q4
$595K Buy
+524
New +$5.63K ﹤0.01% 2268

Other funds holding MXCT

Bank of Montreal's MXCT Position: Q3 2025 in Review

Bank of Montreal sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 341 shares — an estimated $238K sold.

Bank of Montreal first reported a position in MXCT in Q4 2021 and held it in 10 quarters. The position peaked at $23.3M in Q1 2022. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Bank of Montreal reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 341 MaxCyte shares in Q3 2025, an estimated $238K.
  • Bank of Montreal first reported a position in MaxCyte in Q4 2021 and held it in 10 quarters.
  • Bank of Montreal's MaxCyte position peaked at $23.3M in Q1 2022.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.